Here are five things to know about the network:
- Four NIAID-funded clinical trials networks joined forces to form the The COVPN: the Seattle-based HIV Vaccine Trials Network, the Durham, N.C.-based HIV Prevention Trials Network, the Atlanta-based Infectious Diseases Clinical Research Consortium and the Los Angeles-based AIDS Clinical Trials Group. The HIV Vaccine Trials Network will act as the network’s operational center.
- Larry Corey, MD, of the Seattle-based Fred Hutchinson Cancer Research Center and Kathleen Neuzil, MD, of Baltimore-based University of Maryland School of Medicine will lead the network’s vaccine testing.
- Myron S. Cohen, MD, of the University of North Carolina, Chapel Hill and David Stephens, MD, of Atlanta-based Emory University will lead the network’s monoclonal antibody clinical testing.
- The COVPN’s first phase 3 clinical trial, expected to launch this summer, will test Moderna’s mRNA-1273 vaccine.
- The network plans to conduct clinical testing at more than 100 sites domestically and internationally.
More articles on pharmacy:
CVS develops app to read prescription labels for visually impaired patients
Sandoz to supply Civica Rx with 6 injectable drugs
The specialty pharmacy divide: How health systems and payers can find common ground
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
